Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Muntañola

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Urology|January 1, 1977
Nonspecific immunotherapy with BCG vaccine in bladder tumors: a preliminary reportJ A Martinez-Piñeiro, P Muntañola
Archivos Espanoles De Urologia|May 1, 1980
[Local antibiotic therapy in the treatment of chronic bacterial prostatitis]P Muntañola, C Pertusa, J A Martínez-Piñeiro
Actas Urologicas Espanolas|January 1, 1978
[Cryo-immunological response in prostatic cancer]J A Martínez-Piñeiro, F Ruíz, L Hidalgo, et al.
Actas Urologicas Espanolas|January 1, 1980
[Fournier's disease]J M Torronteras, M Mendoza, P Muntañola, et al.
BJU International|April 23, 2002
Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancerJ A Martínez-Piñeiro, N Flores, S Isorna, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Urology|January 1, 1977
Nonspecific immunotherapy with BCG vaccine in bladder tumors: a preliminary reportJ A Martinez-Piñeiro, P Muntañola
Archivos Espanoles De Urologia|May 1, 1980
[Local antibiotic therapy in the treatment of chronic bacterial prostatitis]P Muntañola, C Pertusa, J A Martínez-Piñeiro
Actas Urologicas Espanolas|January 1, 1978
[Cryo-immunological response in prostatic cancer]J A Martínez-Piñeiro, F Ruíz, L Hidalgo, et al.
Actas Urologicas Espanolas|January 1, 1980
[Fournier's disease]J M Torronteras, M Mendoza, P Muntañola, et al.
BJU International|April 23, 2002
Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancerJ A Martínez-Piñeiro, N Flores, S Isorna, et al.
Pageof 1